News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Daily News USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits Yael L. Maxwell June 23, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022
News Conference News EAS 2022 Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol Michael O'Riordan May 26, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows Michael O'Riordan May 04, 2022
News Daily News For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains Michael O'Riordan May 03, 2022
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Daily News USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention Shelley Wood April 26, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol Michael O'Riordan March 15, 2022
News Daily News VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery L.A. McKeown March 04, 2022
News Daily News Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis Michael O'Riordan February 18, 2022
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021